During the past decade, National Masan Tuberculosis Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Masan Tuberculosis Hospital" #1 collaborator was "International Tuberculosis Research Center" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Masan Tuberculosis Hospital" are "Multi-Drug Resistant Tuberculosis" (1 trials), "Refractory Pulmonary Tuberculosis" (1 trials) and "Tuberculosis" (1 trials). Many other conditions were trialed in "National Masan Tuberculosis Hospital" in a lesser frequency.

Most popular intervention types in "National Masan Tuberculosis Hospital" are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood Draw" (1 trials), "CT Scan" (1 trials), "Metronidazole" (1 trials), "PET Scan" (1 trials) and "Pimonidazole hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Masan Tuberculosis Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "National Masan Tuberculosis Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in National Masan Tuberculosis Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Masan Tuberculosis Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".